To test a hypothesis about an effect of GSTM1 in the development of RA in older women, which was previously suggested by Criswell et al. [18], we restricted our analyses to ACPA-positive RA among women ≥60 years (mean age 64 years). Here, PRTN3 is linked to rheumatoid arthritis.